These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 234835)

  • 1. In vitro studies on irreversible binding of halothane metabolite to microsomes.
    Van Dyke RA; Wood CL
    Drug Metab Dispos; 1975; 3(1):51-7. PubMed ID: 234835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid binding of a halothane metabolite. Relationship to lipid peroxidation in vitro.
    Wood CL; Gandolfi AJ; Van Dyke RA
    Drug Metab Dispos; 1976; 4(4):305-13. PubMed ID: 8284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the NADPH-dependent covalent binding of [14C]halothane to human liver microsomes: a role for cytochrome P4502E1 at low substrate concentrations.
    Madan A; Parkinson A
    Drug Metab Dispos; 1996 Dec; 24(12):1307-13. PubMed ID: 8971135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of 14C-toluene to covalently binding metabolites by rat liver microsomes.
    Pathiratne A; Puyear RL; Brammer JD
    Drug Metab Dispos; 1986; 14(4):386-91. PubMed ID: 2873983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on irreversible binding of radioactivity from (14C)halothane to rat hepatic microsomal lipids and protein.
    Van Dyke RA; Gandolf AJ
    Drug Metab Dispos; 1974; 2(5):469-76. PubMed ID: 4156311
    [No Abstract]   [Full Text] [Related]  

  • 6. Anaerobic release of fluoride from halothane. Relationship to the binding of halothane metabolites to hepatic cellular constituents.
    Van Dyke RA; Gandolf AJ
    Drug Metab Dispos; 1976; 4(1):40-4. PubMed ID: 3400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsomal lipids as targets for halothane metabolites.
    Legler D; Van Dyke RA
    Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):395-402. PubMed ID: 7178651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study on the irreversible binding of labeled halothane trichlorofluoromethane, chloroform, and carbon tetrachloride to hepatic protein and lipids in vitro and in vivo.
    Uehleke H; Werner T
    Arch Toxicol; 1975 Dec; 34(4):289-308. PubMed ID: 3152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactivation and covalent binding of halothane in vitro: studies with [3H]- and [14C]halothane.
    Gandolfi AJ; White RD; Sipes IG; Pohl LR
    J Pharmacol Exp Ther; 1980 Sep; 214(3):721-5. PubMed ID: 7400975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of covalent binding from halothane metabolism in hepatic microsomes from phenobarbital-induced and hyperthyroid rats.
    Smith AC; Roberts SM; James RC; Berman LM; Harbison RD
    Xenobiotica; 1988 Aug; 18(8):991-1001. PubMed ID: 3188577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practolol metabolism. III. Irreversible binding of [14C]practolol metabolite(s) to mammalian liver microsomes.
    Orton TC; Lowery C
    J Pharmacol Exp Ther; 1981 Oct; 219(1):207-12. PubMed ID: 6793710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic activation of the halothane metabolite, [14C]2-chloro-1,1-difluoroethene, in hepatic microsomes.
    Baker MT; Bates JN
    Drug Metab Dispos; 1988; 16(2):169-72. PubMed ID: 2898328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic activation of norethisterone (norethindrone) to an irreversibly protein-bound derivative by rat liver microsomes.
    Kappus H; Remmer H
    Drug Metab Dispos; 1975; 3(5):338-44. PubMed ID: 241614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of phospholipids on the differential spectra of the binding of microsomal cytochrome P-450 with substrates].
    Diatlovitskaia EV; Petkova DKh; Lemenovskaia AF; Bergel'son LD
    Biokhimiia; 1984 Apr; 49(4):551-5. PubMed ID: 6733159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme-mediated covalent binding of hydralazine to rat liver microsomes.
    Streeter AJ; Timbrell JA
    Drug Metab Dispos; 1983; 11(3):179-83. PubMed ID: 6135572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vitro metabolism of halothane (2-bromo-2-chloro-1,1,1-trifluoroethane) by hepatic microsomal cytochrome P-450.
    Karashima D; Hirokata Y; Shigematsu A; Furukawa T
    J Pharmacol Exp Ther; 1977 Nov; 203(2):409-16. PubMed ID: 909072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of reductive metabolite, 2-sulfamoylacetylphenol, from zonisamide in rat liver microsomes.
    Nakasa H; Komiya M; Ohmori S; Kitada M; Rikihisa T; Kanakubo Y
    Res Commun Chem Pathol Pharmacol; 1992 Jul; 77(1):31-41. PubMed ID: 1439179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicinal azides. Part 8. The in vitro metabolism of p-substituted phenyl azides.
    Nicholls D; Gescher A; Griffin RJ
    Xenobiotica; 1991 Jul; 21(7):935-43. PubMed ID: 1776269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acids in hepatic microsomal and mitochondrial phospholipids.
    Leyck S; Freundt KJ
    Arzneimittelforschung; 1980; 30(10):1688-90. PubMed ID: 7192107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactivation and covalent binding of halothane to liver macromolecules.
    Sipes IG; Podolsky TL; Brown BR
    Environ Health Perspect; 1977 Dec; 21():171-8. PubMed ID: 612442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.